Sensorin’s continuously self-calibrating pH measurement system will be previewed at Interphex 2009.
New results from the Women’s Health Initiative (WHI) Observational Study provide additional evidence that aspirin may reduce the risk of death in postmenopausal women who have heart disease or who have had a stroke.
An enzyme researchers have studied for years because of its potential connections to cancer, diabetes, heart disease, hypertension, and stroke appears to have yet another major role to play: helping create and maintain the brain.
A showdown is shaping up in some of the nation's most conservative states over embryonic stem cell research.
Gilead Sciences and CV Therapeutics announced the signing of a definitive agreement pursuant to which Gilead will acquire CV Therapeutics for $20.00 per share in cash through a tender offer and second step merger.
Swiss pharmaceutical giant Roche said it has agreed to buy California-based Genentech for $46.8 billion in a takeover described as the largest in Swiss corporate history.
Roche and Genentech announced that they signed a merger agreement under which Roche will acquire the outstanding publicly held interest in Genentech for US $95.00 per share in cash.
President Barack Obama intends to name former New York City Health Commissioner Margaret Hamburg to lead the troubled Food and Drug Administration.
Thermo Fisher Scientific will unveil the Thermo Scientific Cellomics Comet v3.0 BioApplication on booth #1663 at the SOT 48th Annual Meeting and ToxExpo.
A bipartisan group in Congress wants to give the Food and Drug Administration power to approve copies of costly biotech drugs.
Thermo Fisher Scientific introduced the Thermo Scientific Hamilton Distinction II Adaptable Laboratory Furniture System at Pittcon 2009.
Thermo Fisher Scientific launched the Thermo Scientific OMNIC Specta software for Raman applications.
Researchers at the University of Illinois have identified a novel pathway that controls the activity of a key protein involved in inflammation.
Prana Biotechnology Limited announced that its lead compound for the treatment of Alzheimer’s Disease, PBT2, prevents the loss of synapses (the space) between neurons that underlies the process of neurodegeneration in Alzheimer’s Disease.
A molecular switch found in the fat tissue of obese mice is a critical factor in the development of insulin resistance, report scientists at the Salk Institute for Biological Studies.